Literature DB >> 31298922

Prognostic and Predictive Value of Blood Eosinophil Count, Fractional Exhaled Nitric Oxide, and Their Combination in Severe Asthma: A Post Hoc Analysis.

Rahul Shrimanker1, Oliver Keene2, Gareth Hynes1, Sally Wenzel3, Steven Yancey4, Ian D Pavord1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31298922     DOI： 10.1164/rccm.201903-0599LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  15 in total

Review 1.  Anti-IL-5 therapies for asthma.

Authors:  Hugo A Farne; Amanda Wilson; Stephen Milan; Emma Banchoff; Freda Yang; Colin Ve Powell
Journal:  Cochrane Database Syst Rev       Date:  2022-07-12

2.  [Effects of artesunate on eosinophil apoptosis and expressions of Fas and Bcl-2 proteins in asthmatic mice].

Authors:  Ruiyin Wang; Jiangtao Lin; Jingru Wang; Chunxiao Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-01-30

Review 3.  Which Child with Asthma is a Candidate for Biological Therapies?

Authors:  Andrew Bush
Journal:  J Clin Med       Date:  2020-04-24       Impact factor: 4.241

4.  Blood Eosinophil-directed Management of Airway Disease. The Past, Present, and Future.

Authors:  Ian D Pavord
Journal:  Am J Respir Crit Care Med       Date:  2020-09-01       Impact factor: 21.405

5.  Variability of Type 2 inflammatory markers guiding biologic therapy of severe asthma: A 5-year retrospective study from a single tertiary hospital.

Authors:  Hongwen Li; Qing Zhang; Jingru Wang; Shengnan Gao; Chunxiao Li; Jianxin Wang; Shuhua Zhang; Jiangtao Lin
Journal:  World Allergy Organ J       Date:  2021-09-21       Impact factor: 4.084

6.  The influence of individual characteristics and non-respiratory diseases on blood eosinophil count.

Authors:  Rita Amaral; Tiago Jacinto; Andrei Malinovschi; Christer Janson; David Price; João A Fonseca; Kjell Alving
Journal:  Clin Transl Allergy       Date:  2021-06-03       Impact factor: 5.871

7.  Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma.

Authors:  Simon Couillard; Rahul Shrimanker; Rekha Chaudhuri; Adel H Mansur; Lorcan P McGarvey; Liam G Heaney; Stephen J Fowler; Peter Bradding; Ian D Pavord; Timothy S C Hinks
Journal:  Am J Respir Crit Care Med       Date:  2021-09-15       Impact factor: 21.405

Review 8.  Treating severe asthma: Targeting the IL-5 pathway.

Authors:  Stefania Principe; Celeste Porsbjerg; Sisse Bolm Ditlev; Ditte Kjaersgaard Klein; Korneliusz Golebski; Nanna Dyhre-Petersen; Yoni E van Dijk; Job J M H van Bragt; Lente L H Dankelman; Sven-Erik Dahlen; Christopher E Brightling; Susanne J H Vijverberg; Anke H Maitland-van der Zee
Journal:  Clin Exp Allergy       Date:  2021-05-21       Impact factor: 5.018

9.  Diagnostic possibility of the combination of exhaled nitric oxide and blood eosinophil count for eosinophilic asthma.

Authors:  Jiang-Hua Li; Rui Han; Yu-Bo Wang; Min Cheng; Heng-Yi Chen; Wen-Hui Lei; Li Li; Chen Gao; Na-Na Zhao; Nai-Fu Nie; Zhong-Yan Li; Guo-Qing Yin; Shuai Huang; Yong He
Journal:  BMC Pulm Med       Date:  2021-08-09       Impact factor: 3.317

10.  Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide.

Authors:  Simon Couillard; Annette Laugerud; Maisha Jabeen; Sanjay Ramakrishnan; James Melhorn; Timothy Hinks; Ian Pavord
Journal:  Thorax       Date:  2021-08-06       Impact factor: 9.139
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.